AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating Anticholinergic Medications and Neurodegenerative Treatments
This chapter examines the complexities of prescribing anticholinergic medications, especially their interactions with newer schizophrenia treatments. It highlights the nuances of patient management and the importance of individualized dosing strategies while discussing antipsychotic polypharmacy. The conversation also covers recent advancements in psychopharmacology, including the implications of new Alzheimer's drugs and the neuroprotective roles of GLP-1 in neurodegenerative diseases.